Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B
Philip Hampel, Kerstin Römermann, Nanna MacAulay, Wolfgang Löscher
Dyk ned i forskningsemnerne om 'Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B'. Sammen danner de et unikt fingeraftryk.